Is CRON or DFTX more undervalued in 2026?

CirclFi compares Cronos Group Inc. Common Share (CRON) and Definium Therapeutics, Inc. (DFTX) using 13 institutional-grade valuation models. CRON has a Quality of Company score of 5.2/10 while DFTX scores 4.8/10.

Which is a better buy — CRON or DFTX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CRON and DFTX valuations compare?

CRON at $2.84 and DFTX at $24.19 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CRON vs DFTX Valuation Comparison 2026 — Intrinsic Value Analysis

CRON

Medicinal Chemicals & Botanical Products

Cronos Group Inc. Common Share

Quality

5.2

out of 10

Value Trap

SAFE

Price

$2.84

Last close

Models

12/13

Active

DFTX

Medicinal Chemicals & Botanical Products

Definium Therapeutics, Inc.

Quality

4.8

out of 10

Value Trap

SAFE

Price

$24.19

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	CRON Fair Value	CRON Upside	DFTX Fair Value	DFTX Upside
Bayesian DCF	Intrinsic	$2.91	+2.3%	$7.22	-70.2%
Earnings Power Value	Intrinsic	$2.00	-29.6%	$9.39	-58.2%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CRON vs DFTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CRON vs DFTX — Which Stock Is More Undervalued?

CRON scores higher with a 5.2/10 quality rating vs DFTX's 4.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cronos Group Inc. Common Share (CRON) and Definium Therapeutics, Inc. (DFTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CRON currently trades at $2.84 with a QOC of 5.2/10, while DFTX trades at $24.19 with a QOC of 4.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).